Showing results (421-430 of 532) with videos related to
Sort By:
Pageof 54
Die Rehabilitation|December 17, 2011
[Psychosocial predictors of utilization of medical rehabilitation services among prostate cancer patients]C Lehmann, V Beierlein, C Hagen-Aukamp, et al.European Archives of Psychiatry and Clinical Neuroscience|July 25, 2024
Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella reviewJulian Gutzeit, M Weiß, C Nürnberger, et al.Cryo Letters|January 10, 2023
Cryoprotection of humanin-like peptides in seminal plasma for ejaculated spermatozoa of crossbred bullsM Pande, S K Ghosh, S Tyagi, et al.Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patientsJuan Macías, Antonio Rivero, Celia Cifuentes, et al.Infection|October 16, 2012
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBVA Rivero-Juarez, J A Mira, A Camacho, et al.The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyJose A Mira, Juan E Corzo, Antonio Rivero, et al.The Journal of Antimicrobial Chemotherapy|March 19, 2011
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patientsAntonio Rivero-Juárez, José A Mira, Inés Pérez-Camacho, et al.Journal of Cell Science|April 9, 1999
A switch in the cellular localization of macrophage migration inhibitory factor in the rat testis after ethane dimethane sulfonate treatmentA Meinhardt, M Bacher, M K O'Bryan, et al.Chemical Science|August 10, 2018
New enzymatic and mass spectrometric methodology for the selective investigation of gut microbiota-derived metabolitesCaroline Ballet, Mário S P Correia, Louis P Conway, et al.HIV Medicine|July 12, 2018
To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxisM Scholten, I Suárez, M Platten, et al.Pageof 54